News

Results from a study published in the Journal of Psychopharmacology suggest that MDMA combined with psychotherapy may be a safe and effective treatment for symptoms of post-traumatic stress disorder.

The DSM-5 Work Group that first suggested the inclusion of “Psychosis Risk Syndrome” has halfway come to its senses. It has dropped this stigmatizing name in a last ditch repackaging effort to salvage the proposal.

With the availability of drugs for ADHD and Alzheimer disease, more and more healthy people who have no mental health condition have been asking their psychiatrist to prescribe neuroenhancing medications in the hopes of improving their memory, cognitive focus, or attention span. What's an appropriate response when one of your patients asks for a prescription for a drug for this off-label purpose? 

We've asked our editorial board members to nominate recent articles that they believe are of critical importance to psychiatrists. And we've asked them to summarize key study findings-and what they may mean for your practice-in short (5 to 10 minute) podcasts.

My wife, Rika, has completed six years of excruciating residency, passed the board exam the first time that she took it and is completing a similarly demanding medical toxicology fellowship now. She is raising our two beautiful children, works in a dangerous, hostile, challenging inner city ER, teaches, does research, refuses to hire a housekeeper yet keeps the house running like clockwork and puts up with me and all my crap.